India’s drug regulator has directed states to crack down on the unauthorised manufacture and sale of Enclomiphene products. CDSCO said the drug requires central approval and asked authorities to identify violators, take regulatory action and submit compliance reports.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.